Proactiveinvestors USA & Canada Allergan https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Allergan RSS feed en Sun, 12 Jul 2020 08:58:31 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Allergan shrinks net loss in 3Q thanks to Botox sales and lifts earnings forecast https://ca.proactiveinvestors.com/companies/news/208121/allergan-shrinks-net-loss-in-3q-thanks-to-botox-sales-and-lifts-earnings-forecast-208121.html Tue, 30 Oct 2018 11:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/208121/allergan-shrinks-net-loss-in-3q-thanks-to-botox-sales-and-lifts-earnings-forecast-208121.html Carl Icahn snaps up stake in drugmaker Allergan https://ca.proactiveinvestors.com/companies/news/198480/carl-icahn-snaps-up-stake-in-drugmaker-allergan-198480.html Thu, 07 Jun 2018 17:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/198480/carl-icahn-snaps-up-stake-in-drugmaker-allergan-198480.html Investors like the idea of Allergan selling two small units, having a laser focus on core areas https://ca.proactiveinvestors.com/companies/news/197955/investors-like-the-idea-of-allergan-selling-two-small-units-having-a-laser-focus-on-core-areas-197955.html Wed, 30 May 2018 19:08:00 -0400 https://ca.proactiveinvestors.com/companies/news/197955/investors-like-the-idea-of-allergan-selling-two-small-units-having-a-laser-focus-on-core-areas-197955.html Allergan 1Q tops analyst estimates as pharma giant raises full-year guidance https://ca.proactiveinvestors.com/companies/news/196062/allergan-1q-tops-analyst-estimates-as-pharma-giant-raises-full-year-guidance-196062.html Mon, 30 Apr 2018 13:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/196062/allergan-1q-tops-analyst-estimates-as-pharma-giant-raises-full-year-guidance-196062.html Allergan Q4 earnings top Wall Street forecasts; migraine drug succeeds in late-stage trial https://ca.proactiveinvestors.com/companies/news/191241/allergan-q4-earnings-top-wall-street-forecasts-migraine-drug-succeeds-in-late-stage-trial-191241.html Tue, 06 Feb 2018 14:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/191241/allergan-q4-earnings-top-wall-street-forecasts-migraine-drug-succeeds-in-late-stage-trial-191241.html Allergan, Seagate Technology, Urban Outfitters - AFTER HOURS https://ca.proactiveinvestors.com/companies/news/189735/allergan-seagate-technology-urban-outfitters-after-hours-189735.html Tue, 09 Jan 2018 12:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/189735/allergan-seagate-technology-urban-outfitters-after-hours-189735.html Allergan lands FDA approval for schizophrenia drug https://ca.proactiveinvestors.com/companies/news/187160/allergan-lands-fda-approval-for-schizophrenia-drug-187160.html Mon, 13 Nov 2017 19:03:00 -0500 https://ca.proactiveinvestors.com/companies/news/187160/allergan-lands-fda-approval-for-schizophrenia-drug-187160.html Botox maker Allergan pumps up despite third quarter loss https://ca.proactiveinvestors.com/companies/news/186584/botox-maker-allergan-pumps-up-despite-third-quarter-loss-186584.html Wed, 01 Nov 2017 18:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/186584/botox-maker-allergan-pumps-up-despite-third-quarter-loss-186584.html Allergan plc, Moleculin Biotech Inc, Estee Lauder Companies Inc, Abercrombie & Fitch Co - PRE-MARKET https://ca.proactiveinvestors.com/companies/news/186583/allergan-plc-moleculin-biotech-inc-estee-lauder-companies-inc-abercrombie-fitch-co-pre-market-186583.html Wed, 01 Nov 2017 12:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/186583/allergan-plc-moleculin-biotech-inc-estee-lauder-companies-inc-abercrombie-fitch-co-pre-market-186583.html Allergan to appeal against RESTASIS patents verdict https://ca.proactiveinvestors.com/companies/news/185734/allergan-to-appeal-against-restasis-patents-verdict-185734.html Tue, 17 Oct 2017 01:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/185734/allergan-to-appeal-against-restasis-patents-verdict-185734.html Allergan’s Botox gets US FDA green light to treat forehead lines https://ca.proactiveinvestors.com/companies/news/184986/allergans-botox-gets-us-fda-green-light-to-treat-forehead-lines-184986.html Tue, 03 Oct 2017 12:11:00 -0400 https://ca.proactiveinvestors.com/companies/news/184986/allergans-botox-gets-us-fda-green-light-to-treat-forehead-lines-184986.html Allergan shares puff up in pre-market as it announces latest share buy-back and reaffirms dividend commitment https://ca.proactiveinvestors.com/companies/news/184523/allergan-shares-puff-up-in-pre-market-as-it-announces-latest-share-buy-back-and-reaffirms-dividend-commitment-184523.html Mon, 25 Sep 2017 19:24:00 -0400 https://ca.proactiveinvestors.com/companies/news/184523/allergan-shares-puff-up-in-pre-market-as-it-announces-latest-share-buy-back-and-reaffirms-dividend-commitment-184523.html Allergan accused of taking advantage of tribal sovereignty in patent dispute with Mylan https://ca.proactiveinvestors.com/companies/news/183928/allergan-accused-of-taking-advantage-of-tribal-sovereignty-in-patent-dispute-with-mylan-183928.html Wed, 13 Sep 2017 13:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/183928/allergan-accused-of-taking-advantage-of-tribal-sovereignty-in-patent-dispute-with-mylan-183928.html Allergan shares move lower as second quarter losses almost double year-on-year https://ca.proactiveinvestors.com/companies/news/181939/allergan-shares-move-lower-as-second-quarter-losses-almost-double-year-on-year-181939.html Thu, 03 Aug 2017 16:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/181939/allergan-shares-move-lower-as-second-quarter-losses-almost-double-year-on-year-181939.html Allergan edges higher on first quarter beat and full-year guidance upgrade https://ca.proactiveinvestors.com/companies/news/177528/allergan-edges-higher-on-first-quarter-beat-and-full-year-guidance-upgrade-177528.html Tue, 09 May 2017 13:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/177528/allergan-edges-higher-on-first-quarter-beat-and-full-year-guidance-upgrade-177528.html Allergan to push on with final trial for Botox for depression https://ca.proactiveinvestors.com/companies/news/176106/allergan-to-push-on-with-final-trial-for-botox-for-depression-176106.html Thu, 06 Apr 2017 14:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/176106/allergan-to-push-on-with-final-trial-for-botox-for-depression-176106.html Allergan to put forward new acne drug after good trials https://ca.proactiveinvestors.com/companies/news/175468/allergan-to-put-forward-new-acne-drug-after-good-trials-175468.html Mon, 27 Mar 2017 14:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/175468/allergan-to-put-forward-new-acne-drug-after-good-trials-175468.html Gene editing pioneer Editas agrees US$90m collaboration with Allergan https://ca.proactiveinvestors.com/companies/news/174782/gene-editing-pioneer-editas-agrees-us90m-collaboration-with-allergan-174782.html Tue, 14 Mar 2017 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/174782/gene-editing-pioneer-editas-agrees-us90m-collaboration-with-allergan-174782.html Allergan to buy body contouring company Zeltiq Aesthetics https://ca.proactiveinvestors.com/companies/news/173070/allergan-to-buy-body-contouring-company-zeltiq-aesthetics-173070.html Mon, 13 Feb 2017 13:56:00 -0500 https://ca.proactiveinvestors.com/companies/news/173070/allergan-to-buy-body-contouring-company-zeltiq-aesthetics-173070.html Allergan smiling again after Botox boost https://ca.proactiveinvestors.com/companies/news/172872/allergan-smiling-again-after-botox-boost-172872.html Wed, 08 Feb 2017 15:12:00 -0500 https://ca.proactiveinvestors.com/companies/news/172872/allergan-smiling-again-after-botox-boost-172872.html Allergan to buy LifeCell for $2.9bn cash https://ca.proactiveinvestors.com/companies/news/170753/allergan-to-buy-lifecell-for-29bn-cash-170753.html Tue, 20 Dec 2016 20:49:00 -0500 https://ca.proactiveinvestors.com/companies/news/170753/allergan-to-buy-lifecell-for-29bn-cash-170753.html Allergan's results miss on two fronts https://ca.proactiveinvestors.com/companies/news/168419/allergan-s-results-miss-on-two-fronts-168419.html Wed, 02 Nov 2016 15:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/168419/allergan-s-results-miss-on-two-fronts-168419.html Allergan to buy Tobira for US$1.7bn https://ca.proactiveinvestors.com/companies/news/166177/allergan-to-buy-tobira-for-us17bn-166177.html Tue, 20 Sep 2016 13:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/166177/allergan-to-buy-tobira-for-us17bn-166177.html Vitae Pharma downgraded after Allergan takeover offer https://ca.proactiveinvestors.com/companies/news/276023/vitae-pharma-downgraded-after-allergan-takeover-offer-26023.html Wed, 14 Sep 2016 19:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/276023/vitae-pharma-downgraded-after-allergan-takeover-offer-26023.html Tepper tips Allergan, Quorum Health https://ca.proactiveinvestors.com/companies/news/129353/tepper-tips-allergan-quorum-health-129353.html Mon, 15 Aug 2016 20:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/129353/tepper-tips-allergan-quorum-health-129353.html Botox demand underpins Allergan results https://ca.proactiveinvestors.com/companies/news/129118/botox-demand-underpins-allergan-results-129118.html Mon, 08 Aug 2016 14:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/129118/botox-demand-underpins-allergan-results-129118.html Botox owner Allergan gets green light for double chin treatment in Europe https://ca.proactiveinvestors.com/companies/news/127761/botox-owner-allergan-gets-green-light-for-double-chin-treatment-in-europe-127761.html Fri, 01 Jul 2016 12:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/127761/botox-owner-allergan-gets-green-light-for-double-chin-treatment-in-europe-127761.html Not tonight; he's got a headache https://ca.proactiveinvestors.com/companies/news/127001/not-tonight-he-s-got-a-headache-127001.html Fri, 10 Jun 2016 13:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/127001/not-tonight-he-s-got-a-headache-127001.html Allergan shares rise after $10bn buyback plan https://ca.proactiveinvestors.com/companies/news/125770/allergan-shares-rise-after-10bn-buyback-plan-125770.html Tue, 10 May 2016 15:47:00 -0400 https://ca.proactiveinvestors.com/companies/news/125770/allergan-shares-rise-after-10bn-buyback-plan-125770.html Potential merger of Allergan and Pfizer sparks tax debate https://ca.proactiveinvestors.com/companies/news/116876/potential-merger-of-allergan-and-pfizer-sparks-tax-debate-116876.html Fri, 30 Oct 2015 10:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/116876/potential-merger-of-allergan-and-pfizer-sparks-tax-debate-116876.html Allergan, Pfizer confirm preliminary merger talks https://ca.proactiveinvestors.com/companies/news/116842/allergan-pfizer-confirm-preliminary-merger-talks-116842.html Fri, 30 Oct 2015 07:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/116842/allergan-pfizer-confirm-preliminary-merger-talks-116842.html Allergan buys rights to Merck’s two migraine drugs for $250 mln upfront https://ca.proactiveinvestors.com/companies/news/114422/allergan-buys-rights-to-mercks-two-migraine-drugs-for-250-mln-upfront-114422.html Tue, 07 Jul 2015 21:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/114422/allergan-buys-rights-to-mercks-two-migraine-drugs-for-250-mln-upfront-114422.html Allergan agrees to buy Oculeve for $125 mln in cash https://ca.proactiveinvestors.com/companies/news/114421/allergan-agrees-to-buy-oculeve-for-125-mln-in-cash-114421.html Mon, 06 Jul 2015 20:44:00 -0400 https://ca.proactiveinvestors.com/companies/news/114421/allergan-agrees-to-buy-oculeve-for-125-mln-in-cash-114421.html Allergan to buy Kythera Biopharma in $2.1 bln cash-and-stock deal https://ca.proactiveinvestors.com/companies/news/114420/allergan-to-buy-kythera-biopharma-in-21-bln-cash-and-stock-deal-114420.html Wed, 17 Jun 2015 20:47:00 -0400 https://ca.proactiveinvestors.com/companies/news/114420/allergan-to-buy-kythera-biopharma-in-21-bln-cash-and-stock-deal-114420.html Actavis boosts Q1 revenue 59% on Allergan acquisition https://ca.proactiveinvestors.com/companies/news/106583/actavis-boosts-q1-revenue-59-on-allergan-acquisition-106583.html Mon, 11 May 2015 13:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/106583/actavis-boosts-q1-revenue-59-on-allergan-acquisition-106583.html Allergan accepts $66 bln bid from Actavis https://ca.proactiveinvestors.com/companies/news/104243/allergan-accepts-66-bln-bid-from-actavis-58201.html Mon, 17 Nov 2014 18:22:00 -0500 https://ca.proactiveinvestors.com/companies/news/104243/allergan-accepts-66-bln-bid-from-actavis-58201.html Allergan reaches truce with hostile bidders on special shareholder meeting https://ca.proactiveinvestors.com/companies/news/103260/allergan-reaches-truce-with-hostile-bidders-on-special-shareholder-meeting-56828.html Tue, 16 Sep 2014 13:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/103260/allergan-reaches-truce-with-hostile-bidders-on-special-shareholder-meeting-56828.html Allergan sues Valeant, Pershing and Ackman for insider trading https://ca.proactiveinvestors.com/companies/news/102626/allergan-sues-valeant-pershing-and-ackman-for-insider-trading-55885.html Fri, 01 Aug 2014 19:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/102626/allergan-sues-valeant-pershing-and-ackman-for-insider-trading-55885.html Allergan reports higher Q2 net and sales, to cut 1,500 jobs https://ca.proactiveinvestors.com/companies/news/102390/allergan-reports-higher-q2-net-and-sales-to-cut-1500-jobs-55574.html Mon, 21 Jul 2014 13:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/102390/allergan-reports-higher-q2-net-and-sales-to-cut-1500-jobs-55574.html Allergan rises after settling Pershing Square suit over poison pill https://ca.proactiveinvestors.com/companies/news/102059/allergan-rises-after-settling-pershing-square-suit-over-poison-pill-55092.html Fri, 27 Jun 2014 19:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/102059/allergan-rises-after-settling-pershing-square-suit-over-poison-pill-55092.html Ackman's Pershing seeks court ruling to clarify Allergan's poison pill https://ca.proactiveinvestors.com/companies/news/101806/ackmans-pershing-seeks-court-ruling-to-clarify-allergans-poison-pill-54752.html Fri, 13 Jun 2014 15:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/101806/ackmans-pershing-seeks-court-ruling-to-clarify-allergans-poison-pill-54752.html Allergan turns down Valeant's latest sweetened $54 bln buyout bid https://ca.proactiveinvestors.com/companies/news/101733/allergan-turns-down-valeants-latest-sweetened-54-bln-buyout-bid-54650.html Tue, 10 Jun 2014 14:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/101733/allergan-turns-down-valeants-latest-sweetened-54-bln-buyout-bid-54650.html